New research from Virginia Tech identifies key molecular changes behind age-related memory loss — and shows they can be reversed. By targeting specific brain processes with advanced gene-editing tools, scientists improved memory performance in older animals, opening new possibilities for dementia research.
(From left) Associate Professor Tim Jarome works with seniors Harshini Venkat and Keira Currier at his lab in the School of Animal Sciences, where they collect protein samples for a Western blot.
(Source: Marya Barlow/ Virginia Tech)
Memory loss may not simply be a symptom of getting older. New research from Virginia Tech shows that it’s tied to specific molecular changes in the brain and that adjusting those processes can improve memory. In two complementary studies, Timothy Jarome, associate professor in the College of Agriculture and Life Sciences’ School of Animal Sciences, and his graduate students used gene-editing tools to target those age-related changes to improve memory performance in older subjects. The work was conducted on rats, a standard model for studying how memory changes with age.
“Memory loss affects more than a third of people over 70, and it’s a major risk factor for Alzheimer’s disease,” said Jarome, who also holds an appointment in the School of Neuroscience. “This work shows that memory decline is linked to specific molecular changes that can be targeted and studied. If we can understand what’s driving it at the molecular level, we can start to understand what goes wrong in dementia and eventually use that knowledge to guide new approaches to treatment.”
In the first study, published in the journal Neuroscience and led by Jarome and doctoral student Yeeun Bae, the team examined a process called K63 polyubiquitination. This process acts as a molecular tagging system that tells proteins inside the brain how to behave. When the system functions normally, it helps brain cells communicate and form memories.
Jarome and his team found that aging disrupts K63 polyubiquitination in two distinct areas of the brain. In the hippocampus, which helps form and retrieve memories, levels of K63 polyubiquitination increase with age. Using the CRISPR-dCas13 RNA editing system to reduce these levels, the researchers were able to improve memory in older rats.
In the amygdala, which is important for emotional memory, the researchers noted that K63 polyubiquitination declines with age. By reducing it even further, they were able to boost memory in older rats.
“Together, these findings reveal the important functions of K63 polyubiquitination in the brain’s aging process,” Jarome said. “In both regions, adjusting this one molecular process helped improve memory.”
Reactivating a Gene that Supports Memory
A second study, published in the Brain Research Bulletin and led by Jarome with doctoral student Shannon Kincaid, focused on IGF2, a growth-factor gene that supports memory formation. As the brain ages, IGF2 activity drops as the gene becomes chemically silenced in the hippocampus.
“IGF2 is one of a small number of genes in our DNA that’s imprinted, which means it’s expressed from only one parental copy,” Jarome said. “When that single copy starts to shut down with age, you lose its benefit.”
The researchers found that this silencing happens through DNA methylation, a natural process in which chemical tags accumulate on the gene and switch it off. Using a precise gene-editing tool, CRISPR-dCas9, they removed those tags and reactivated the gene. The result was better memory in older rats.
“We essentially turned the gene back on,” Jarome said. “When we did that, the older animals performed much better. Middle-aged animals that didn’t yet have memory problems weren’t affected, which tells us timing matters. You have to intervene when things start to go wrong.”
Together, the two studies show that memory loss is not caused by a single molecule or pathway and that multiple molecular systems likely contribute to how the brain ages.
“We tend to look at one molecule at a time, but the reality is that many things are happening at once,” he said. “If we want to understand why memory declines with age or why we develop Alzheimer’s disease, we have to look at the broader picture.”
Collaborative, Graduate-Led Research
Both studies were driven by graduate researchers in Jarome’s lab and supported through collaborations with scientists at Rosalind Franklin University, Indiana University, and Penn State. Yeeun Bae, who completed her doctoral work with Jarome in the School of Animal Sciences, led the study on K63 polyubiquitination. Shannon Kincaid, a doctoral student in the same program, led the study on IGF2.
“These projects represent the kind of graduate-led, collaborative research that defines our work,” Jarome said. “Our students are deeply involved in designing experiments, analyzing data, and helping shape the scientific questions we pursue.”
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
The research was supported by the National Institutes of Health and the American Federation for Aging Research.
“Everyone has some memory decline as they get older,” he said. “But when it becomes abnormal, the risk for Alzheimer’s disease rises. What we’re learning is that some of those changes happening at a molecular level can be corrected — and that gives us a path forward to potential treatments.”
Original Study: Increased DNA methylation of Igf2 in the male hippocampus regulates age-related deficits in synaptic plasticity and memory; https://doi.org/10.1016/j.brainresbull.2025.111509; Brain Research Bulletin